Hydrogen inhalation ameliorates hepatic inflammation and modulates gut microbiota in rats with high-fat diet-induced non-alcoholic fatty liver disease.

[1]  Hongguang Chen,et al.  Effect of molecular hydrogen treatment on Sepsis‐Associated encephalopathy in mice based on gut microbiota , 2022, CNS neuroscience & therapeutics.

[2]  M. Barančík,et al.  Biological Effects of Hydrogen Water on Subjects with NAFLD: A Randomized, Placebo-Controlled Trial , 2022, Antioxidants.

[3]  F. Liu,et al.  Alteration of fecal microbiome and metabolome by mung bean coat improves diet-induced non-alcoholic fatty liver disease in mice , 2022, Food Science and Human Wellness.

[4]  W. Chen,et al.  A randomized, placebo‐controlled clinical trial of hydrogen/oxygen inhalation for non‐alcoholic fatty liver disease , 2022, Journal of cellular and molecular medicine.

[5]  Yun Wang,et al.  In vivo microelectrode monitoring of real-time hydrogen concentration in different tissues of rats after inhaling hydrogen gas , 2021, Medical gas research.

[6]  S. Qin,et al.  Protective Effect of Molecular Hydrogen Following Different Routes of Administration on D-Galactose-Induced Aging Mice , 2021, Journal of inflammation research.

[7]  Zhaokui Jin,et al.  Nanocapsule-mediated sustained H2 release in the gut ameliorates metabolic dysfunction-associated fatty liver disease. , 2021, Biomaterials.

[8]  S. Ostojić.  Hydrogen-rich water as a modulator of gut microbiota? , 2021 .

[9]  Z. Lei,et al.  Metagenomic insights into the effects of nanobubble water on the composition of gut microbiota in mice. , 2020, Food & function.

[10]  S. Qin,et al.  Hydrogen inhalation alleviates nonalcoholic fatty liver disease in metabolic syndrome rats , 2020, Molecular medicine reports.

[11]  Jiankang Liu,et al.  L-Arabinose Elicits Gut-Derived Hydrogen Production and Ameliorates Metabolic Syndrome in C57BL/6J Mice on High-Fat-Diet , 2019, Nutrients.

[12]  I. Bergheim,et al.  Positive effect of an electrolyzed reduced water on gut permeability, fecal microbiota and liver in an animal model of Parkinson’s disease , 2019, PloS one.

[13]  M. Roden,et al.  Are Lifestyle Therapies Effective for NAFLD Treatment? , 2019, Trends in Endocrinology & Metabolism.

[14]  Y. Xin,et al.  Role and effective therapeutic target of gut microbiota in NAFLD/NASH. , 2019, Experimental and therapeutic medicine.

[15]  Wei Li,et al.  Global liver disease burdens and research trends: Analysis from a Chinese perspective. , 2019, Journal of hepatology.

[16]  S. Ostojić,et al.  Hydrogen-rich water reduces liver fat accumulation and improves liver enzyme profiles in patients with non-alcoholic fatty liver disease: a randomized controlled pilot trial. , 2019, Clinics and research in hepatology and gastroenterology.

[17]  D. Masuero,et al.  Spinach consumption ameliorates the gut microbiota and dislipaemia in rats with diet-induced non-alcoholic fatty liver disease (NAFLD). , 2019, Food & function.

[18]  D. J. Kim,et al.  Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease , 2019, Expert review of gastroenterology & hepatology.

[19]  X. Yao,et al.  Modulation of the Gut Microbiota in Rats by Hugan Qingzhi Tablets during the Treatment of High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease , 2018, Oxidative medicine and cellular longevity.

[20]  Tyler W LeBaron,et al.  Effects of alkaline-electrolyzed and hydrogen-rich water, in a high-fat-diet nonalcoholic fatty liver disease mouse model , 2018, World journal of gastroenterology.

[21]  D. Hou,et al.  Modulation of Gut Microbiota by Lonicera caerulea L. Berry Polyphenols in a Mouse Model of Fatty Liver Induced by High Fat Diet , 2018, Molecules.

[22]  Wen-Jing Gong,et al.  Effects of the long-term consumption of hydrogen-rich water on the antioxidant activity and the gut flora in female juvenile soccer players from Suzhou, China , 2018, Medical gas research.

[23]  Gianluca Svegliati-Baroni,et al.  Lipotoxicity and the gut-liver axis in NASH pathogenesis. , 2018, Journal of hepatology.

[24]  Michael Charlton,et al.  The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases , 2018, Hepatology.

[25]  Xiang Wang,et al.  High-content hydrogen water-induced downregulation of miR-136 alleviates non-alcoholic fatty liver disease by regulating Nrf2 via targeting MEG3 , 2017, Biological chemistry.

[26]  Xuejun Sun,et al.  Hydrogen-rich saline improves non‑alcoholic fatty liver disease by alleviating oxidative stress and activating hepatic PPARα and PPARγ. , 2017, Molecular medicine reports.

[27]  A. Schoepfer,et al.  Therapy: Positioning of dilation in eosinophilic oesophagitis , 2016, Nature Reviews Gastroenterology &Hepatology.

[28]  Lawrence A. David,et al.  The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota , 2016, Hepatology.

[29]  Patrice D. Cani,et al.  Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling , 2015, Cell metabolism.

[30]  P. Vajro,et al.  Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease. , 2014, World journal of gastroenterology.

[31]  S. Ohta.  Molecular hydrogen as a preventive and therapeutic medical gas: initiation, development and potential of hydrogen medicine. , 2014, Pharmacology & therapeutics.

[32]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[33]  Robert C. Edgar,et al.  UPARSE: highly accurate OTU sequences from microbial amplicon reads , 2013, Nature Methods.

[34]  Junfang Wu,et al.  Gut microbiota composition modifies fecal metabolic profiles in mice. , 2013, Journal of proteome research.

[35]  H. Flint,et al.  The influence of diet on the gut microbiota. , 2013, Pharmacological research.

[36]  H. Shiraha,et al.  Hydrogen‐rich water prevents progression of nonalcoholic steatohepatitis and accompanying hepatocarcinogenesis in mice , 2012, Hepatology.

[37]  G. Nardone,et al.  Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease. , 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[38]  Rob Knight,et al.  UCHIME improves sensitivity and speed of chimera detection , 2011, Bioinform..

[39]  Ashraf Shoeib,et al.  Frequency of Firmicutes and Bacteroidetes in gut microbiota in obese and normal weight Egyptian children and adults , 2011, Archives of medical science : AMS.

[40]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[41]  Martin Hartmann,et al.  Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities , 2009, Applied and Environmental Microbiology.

[42]  D. Brenner,et al.  Toll‐like receptors and adaptor molecules in liver disease: Update , 2008, Hepatology.

[43]  Ruiqiang Li,et al.  SOAP: short oligonucleotide alignment program , 2008, Bioinform..

[44]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[45]  G. Svegliati-Baroni,et al.  Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH , 2019, Transplantation.

[46]  S. Salzberg,et al.  FLASH: fast length adjustment of short reads to improve genome assemblies , 2011, Bioinform..